Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001046839 | SCV001210757 | pathogenic | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2024-08-14 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 681 of the CRB1 protein (p.Cys681Tyr). This variant is present in population databases (rs62636266, gnomAD 0.0009%). This missense change has been observed in individual(s) with CRB1-related conditions (PMID: 17525851, 24265693, 30576320, 32865313). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99874). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CRB1 protein function. For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000086312 | SCV001248709 | pathogenic | not provided | 2017-03-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000086312 | SCV001905546 | pathogenic | not provided | 2021-09-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453016 | SCV004179998 | pathogenic | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453015 | SCV004179999 | pathogenic | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453016 | SCV004211182 | pathogenic | Leber congenital amaurosis 8 | 2023-06-29 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004815176 | SCV005069231 | likely pathogenic | Retinal dystrophy | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004815176 | SCV005885694 | pathogenic | Retinal dystrophy | 2025-02-26 | criteria provided, single submitter | clinical testing | Variant summary: CRB1 c.2042G>A (p.Cys681Tyr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251086 control chromosomes. c.2042G>A has been reported in the literature in multiple individuals affected with Leber congenital amaurosis (examples: Lotery_2001, Preising_2007, Eisenberger_2013, Weisschuh_2018, Sallum_2020, Skorczyk-Werner_2022). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 17525851, 30576320, 24265693, 32865313, 11231775, 36369640). ClinVar contains an entry for this variant (Variation ID: 99874). Based on the evidence outlined above, the variant was classified as pathogenic. |
Retina International | RCV000086312 | SCV000118458 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV001831900 | SCV002090158 | likely pathogenic | Leber congenital amaurosis | 2020-11-04 | no assertion criteria provided | clinical testing |